Life Technologies Offers New Rapid DNA Platform

               Life Technologies Offers New Rapid DNA Platform

- Company signs exclusive global distribution agreement with LGC Forensics

- A first-of-its-kind, ParaDNA® screens for the presence of DNA in 75 minutes
to aid law enforcement

PR Newswire

CARLSBAD, Calif., April 1, 2013

CARLSBAD, Calif., April 1, 2013 /PRNewswire/ --As the global market leader in
human identification, Life Technologies Corporation (NASDAQ: LIFE) announced
today it signed a global exclusive agreement with LGC Forensics for the right
to distribute ParaDNA®, a portable rapid DNA system that determines the
quality of human DNA faster and more economically than any existing method.
This announcement is the second in a series of new Rapid DNA products the
company will introduce to expand the landscape beyond traditional Rapid DNA

Life Technologies launched its portfolio of Rapid DNA products with
GlobalFiler™, which is used to dramatically reduce the time to process samples
within forensic laboratories. Rapid DNA emerging technology platforms enable
samples to be identified in real-time and also at the crime scene or location
other than the centralized processing laboratory. This capability allows law
enforcement professionals around the globe to make informed decisions more
quickly and economically.

ParaDNA is an easy-to-use, high-speed DNA testing system that allows onsite
rapid identification of samples suitable to submit for more detailed analysis.
The system helps reduce laboratory backlogs and turnaround times for
processing, so investigators can focus their attention on samples most likely
to generate a genetic profile.

"ParaDNA is the latest among a series of innovative products available from
Life Technologies that will revolutionize – through speed and simplicity – the
way law enforcement and labs process DNA samples," said Nadia Altomare, head
of the Human Identification business for Life Technologies. "We are excited
to be leading the path toward faster and decentralized DNA analysis. ParaDNA,
along with GlobalFiler, are the first such products to provide this real-time
testing to customers."

How ParaDNA Works

Samples obtained at a crime scene are tested within a closed system to reduce
cross contamination. Within 75 minutes, the ParaDNA system indicates whether
samples contain a useable DNA profile.

"We know that DNA profiling can help establish whether or not there is a link
between a suspect and a crime," said Mark Dearden, Business Unit Director of
ParaDNA for LGC Forensics. "ParaDNA enables a quick and simple, on-the-spot,
presumptive DNA screen to complement submissions policies – and could save
significant time and cost in the investigative process. We are delighted that
this partnership with Life Technologies will allow us to 'fast-forward' those
samples most likely to be informative, by placing the technology straight in
the hands of investigators."

About Life Technologies

Life Technologies Corporation(NASDAQ:LIFE) is a global biotechnology company
that is committed to providing the most innovative products and services to
leading customers in the fields of scientific research, genetic analysis and
applied sciences. With a presence in more than 180 countries, the company's
portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents
and licenses that span the entire biological spectrum -- scientific
exploration, molecular diagnostics, 21^stcentury forensics, regenerative
medicine and agricultural research. Life Technologies has approximately 10,000
employees and had sales of $3.8 billion in 2012.

About LGC Forensics

LGC ( is the international science-based company and market
leader in the laboratory services, measurement standards, reference materials,
genomics and proficiency testing marketplaces. LGC operates in a variety of
international markets, which underpin the safety, health and security of the
public and the regulation of industry, for both private and public sector

LGC is the UK's largest, full service independent forensic science provider,
with a wide variety of customers drawn from police forces and other law
enforcement agencies, UK government departments, defence lawyers, as well as
private corporations and individuals. LGC provides full casework and
analytical services in DNA techniques, controlled drugs, toxicology, ecology,
questioned documents, digital crime, firearms and ballistics and forensic
pathology in support of modern policing.

Its operations are extensively accredited to international quality standards
such as ISO/IEC 17025. With headquarters in Teddington, South West London,
the LGC Group employs over 1,900 staff, operating out of 22 countries, with
laboratories and centres across Europe and the US, as well as sites in Brazil,
China and India. The genesis of LGC dates back to 1842, and for more than 100
years it has been home to the UK statutory function of Government Chemist.
Formerly the Laboratory of the Government Chemist, LGC was privatised in 1996
and is now majority-owned by funds managed by Bridgepoint.

Life Technologies' Safe Harbor Statement

This press release includes forward-looking statements about our anticipated
results that involve risks and uncertainties. Some of the information
contained in this press release, including, but not limited to, statements as
to industry trends and Life Technologies' plans, objectives, expectations and
strategy for its business, contains forward-looking statements that are
subject to risks and uncertainties that could cause actual results or events
to differ materially from those expressed or implied by such forward-looking
statements. Any statements that are not statements of historical fact are
forward-looking statements. When used, the words "believe," "plan," "intend,"
"anticipate," "target," "estimate," "expect" and the like, and/or future tense
or conditional constructions ("will," "may," "could," "should," etc.), or
similar expressions, identify certain of these forward-looking statements.
Important factors which could cause actual results to differ materially from
those in the forward-looking statements are detailed in filings made byLife
Technologies with the Securities and Exchange Commission. Life Technologies
undertakes no obligation to update or revise any such forward-looking
statements to reflect subsequent events or circumstances.


Life Technologies Media Contact:
Patty Zamora
Corporate Communications
Tel: 760-476-7818

LGC Forensics Media Contact:
Julian Quigley
Communications/Press Officer
Tel: +44 (0)20 8943 8491

SOURCE Life Technologies Corporation
Press spacebar to pause and continue. Press esc to stop.